Anti-GP2 IgA

A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

Sumera Rizvi, Ju Dong Yang, Gregory James Gores

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)4-5
Number of pages2
JournalGut
Volume66
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Sclerosing Cholangitis
Cholangiocarcinoma
Biomarkers
anti-IgA

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Anti-GP2 IgA : A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis? / Rizvi, Sumera; Yang, Ju Dong; Gores, Gregory James.

In: Gut, Vol. 66, No. 1, 01.01.2017, p. 4-5.

Research output: Contribution to journalComment/debate

@article{ef2e21127fd741afab655748e881221c,
title = "Anti-GP2 IgA: A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?",
author = "Sumera Rizvi and Yang, {Ju Dong} and Gores, {Gregory James}",
year = "2017",
month = "1",
day = "1",
doi = "10.1136/gutjnl-2016-312492",
language = "English (US)",
volume = "66",
pages = "4--5",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Anti-GP2 IgA

T2 - A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

AU - Rizvi, Sumera

AU - Yang, Ju Dong

AU - Gores, Gregory James

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85013140221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013140221&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2016-312492

DO - 10.1136/gutjnl-2016-312492

M3 - Comment/debate

VL - 66

SP - 4

EP - 5

JO - Gut

JF - Gut

SN - 0017-5749

IS - 1

ER -